Xylem ist ein globales Wassertech-Unternehmen, das sich der Lösung kritischer Probleme der Wassereinfrastruktur widmet und Produkte für Wasseraufbereitung, -transport und -analytik bereitstellt, die für die Klimaanpassung unverzichtbar sind.
Xylem ist ein führendes Wassertechnologieunternehmen, das intelligente Infrastrukturlösungen bereitstellt, einschließlich Pumpen, Behandlungssysteme, Analytik und digitale Überwachungsplattformen, die Versorgungsunternehmen und Industrien helfen, Wasser effizienter über den gesamten Wasserzyklus hinweg zu bewirtschaften.
Data updated Feb 15 · Source: Twelve Data
Xylem is a premier pure-play water technology company, offering solutions across water transport, treatment, testing, and smart infrastructure. The 2023 acquisition of Evoqua Water Technologies significantly expanded its treatment capabilities and created meaningful cross-selling opportunities. With a P/E of 25.47 and EPS of $5.03, the stock trades at a premium but one arguably justified by its dominant market position in a secular growth industry. Global water scarcity, aging infrastructure, and tightening regulations provide powerful long-term tailwinds. The recent pullback of ~14.5% over 90 days brings the price closer to fair value territory, currently sitting well below its 50-day moving average of $138.47. Bull case: irreplaceable positioning in essential water infrastructure with recurring revenue streams and margin expansion from Evoqua synergies. Bear case: integration risks, cyclical exposure to municipal spending, and elevated valuation relative to industrial peers. The balance sheet carries acquisition-related debt that warrants monitoring. For investors seeking exposure to water megatrends and climate resilience, Xylem remains a cornerstone holding with strong competitive moats.
Xylem Inc. (XYL) stands as a premier pure-play in the water technology sector, offering essential solutions for water transport, treatment, and testing. The company benefits from strong secular tailwinds, including global water scarcity and the urgent need to upgrade aging utility infrastructure. The recent integration of Evoqua Water Technologies has further solidified its competitive moat by expanding its service capabilities. Currently trading at $128.92 with a P/E ratio of 26.64, valuation remains elevated compared to broader industrials but reflects the premium assigned to its market leadership and ESG credentials. The stock has recently pulled back significantly from its 52-week high of $154.27 and is trading below its 50-day moving average, potentially offering a tactical entry point for long-term investors. While cyclical risks in industrial spending persist, Xylem's diverse portfolio provides resilience.
Latest from Otrai
A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.
The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.
Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.
Jeder Trader hat eine Strategie, die in seinem Kopf großartig aussieht. Backtesting ist die Art herauszufinden, ob sie tatsächlich funktioniert. Hier erfahren Sie, wie Sie Strategien richtig testen, welche Kennzahlen wichtig sind und warum die meisten Backtest-Ergebnisse zu gut sind, um wahr zu sein.
Powered by Rexiew